Certificates of Analysis
Peptide Testing

BioPlex Peptide's £30,000 Commitment to Independent Laboratory Testing

Raising the Standard for Independent Peptide Testing, Product Quality and Complete Transparency in the UK Research Market

As the UK research peptide market continues to grow, lower prices do not always mean better value. Increased competition and cost-cutting can place product quality, consistency and transparency at risk.

BioPlex Peptides believes customers deserve more than unsupported claims. That is why we are investing approximately £30,000 over the next 12 months in independent laboratory testing through our US testing partner, Vanguard Laboratory.

Each independent test costs approximately $250, making this a substantial and ongoing investment in transparency. We believe it is a necessary one.

Our first collection of testing certificates will be published on this page within the next few weeks. After that, we intend to commission testing every month, selecting different products and batches from across the BioPlex range.

Over time, this page will become a growing portfolio of independent testing results, allowing customers and researchers to view the available documentation in one clear and accessible location.


Our Partnership With Vanguard Laboratory

BioPlex Peptides is working directly with Vanguard Laboratory in the United States to independently assess selected products from our research range.

This partnership enables us to build a structured, ongoing testing programme rather than publishing a small number of certificates and leaving them unchanged indefinitely. New results will be added regularly as different products and batches are selected for analysis.

Each published certificate will be displayed with the relevant product name, testing date, available sample or batch reference, analytical method and reported laboratory findings.

Learn More About Our Testing Partnership With Vanguard Laboratory ⟶


What Our Testing Programme Means

Our commitment includes:

  • Approximately £30,000 allocated to independent testing over 12 months
  • New products and batches selected for testing each month
  • Certificates published openly on this page
  • Clear identification of the product and testing date
  • Regular updates as new laboratory results become available
  • A growing, accessible record of BioPlex testing documentation


Transparency Without Misleading Claims

A certificate of analysis represents the specific sample submitted to the laboratory for testing. It should not be treated as permanent proof covering every product, batch or future sample.

For this reason, BioPlex is building an ongoing programme of testing and regularly updated documentation. We will present the results supplied by the laboratory clearly, without altering the findings or using certificates to make claims beyond what was actually tested.


First Testing Results Coming Soon!!

Our first group of independent testing certificates is currently being prepared and is expected to appear on this page within the next few weeks.

Please return regularly as we continue adding results and building one of the most comprehensive, transparent testing portfolios available from a UK research peptide supplier.